title: Pneumatosis intestinalis and imatinib mesylate.
authors.affiliation: Department of Haematology, Our Lady's Children's Hospital, Crumlin, Dublin, Ireland, orafferc@gmail.com.
authors.forename: Ciara
authors.initials: C
authors.lastname: O'Rafferty
authors.forename: Fiona
authors.initials: F
authors.lastname: McElligott
authors.forename: Lorna
authors.initials: L
authors.lastname: Storey
authors.forename: Aengus
authors.initials: A
authors.lastname: O'Marcaigh
authors.forename: Owen
authors.initials: O
authors.lastname: Smith
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001215:Asparaginase / Q000008:administration & dosage; D001549:Benzamides / Q000008:administration & dosage / Q000009:adverse effects*; D002675:Child, Preschool; D000069439:Dasatinib; D003630:Daunorubicin / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage; D057915:Drug Substitution; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D010289:Parenteral Nutrition, Total; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects*; D011006:Pneumatosis Cystoides Intestinalis / Q000139:chemically induced*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications / Q000188:drug therapy*; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D011743:Pyrimidines / Q000008:administration & dosage / Q000009:adverse effects*; D012008:Recurrence; D013844:Thiazoles / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D013844:Thiazoles; D014750:Vincristine; D003907:Dexamethasone; D000068877:Imatinib Mesylate; D001215:Asparaginase; D000069439:Dasatinib; D003630:Daunorubicin